Applicant, as named in the Orange Book

Acrotech Biopharma

Next listed expiry: Beleodaq on 27 Oct 2027. 4 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Beleodaq belinostat	belinostat	206256	27 Oct 2027	patent
Evomela melphalan hydrochloride	melphalan hydrochloride	207155	30 Jan 2034	patent
Adquey difamilast	difamilast	219474	31 Dec 2036	patent
Khapzory levoleucovorin	levoleucovorin	211226	25 Mar 2039	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Folotyn · 2 strengths pralatrexate	pralatrexate	022468	open now	no listed protection